deaths (OS)

mNSCLC - L2 - PDL1 positive metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) mNSCLC - L2 - PDL1 positive

versus docetaxel
avelumab alone vs. docetaxel 1 0.90 [0.72; 1.12], 1 RCT, I2=0%
inconclusive result